Human papillomavirus vaccination status among university students in Southern Thailand: A cross-sectional study.
Prev Med Rep
; 46: 102857, 2024 Oct.
Article
en En
| MEDLINE
| ID: mdl-39253725
ABSTRACT
Objective:
Human papillomavirus (HPV) commonly causes transmissible diseases worldwide; however, HPV vaccines are not available among some at-risk populations. Since 2017, HPV vaccination has been recommended for females aged 11-12 years in Thailand. However, studies on the coverage and HPV vaccination prevalence are limited. This study aimed to explore the prevalence and factors associated with HPV vaccination among Thai university students.Methods:
Data for this cross-sectional study were randomly collected using paper-based questionnaires from university students aged 18-26 years during October 17-27, 2023.Results:
Of 1,093 participants, 57.6 % were female, and 53.5 % were from non-urban areas. The median age was 20 years. One-third of the participants were from low-income families. The overall HPV vaccine coverage rates were 7.51 % and 0.87 % in female and male students, respectively. Female sex, being from a high-income family, studying in health science faculties, originating from an urban area, having one or both parents completing university educations, and having healthcare providers as family members increased the odds of receiving the HPV vaccine. The accuracy of HPV vaccine literacy among participants who reported that they "know about the HPV vaccine" was adequate, except for the fact that HPV vaccine was sex-neutral.Conclusions:
The HPV vaccine coverage rate among Thai university students was low owing to several factors. HPV and HPV vaccine education should be provided to populations that can still benefit from receiving the HPV vaccine.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Prev Med Rep
Año:
2024
Tipo del documento:
Article
País de afiliación:
Tailandia
Pais de publicación:
Estados Unidos